Utility of Eosinophil-derived Neurotoxin as a Biomarker in Eosinophilic Esophagitis: Results From a Randomized, Double-blind, Controlled Trial of Mepolizumab in Pediatric Patients

Autor: Gupta, S., Kita, H., Collins, M., Perschy, T., Heath, A., Jurgensen, C.
Zdroj: In The Journal of Allergy and Clinical Immunology 2010 125(2) Supplement 1:AB234-AB234
Databáze: ScienceDirect